Project Number 1R43AG040935-01A1 Agency/Funding Organization NIA Funding Year 2012 View Full Project Details for DEVELOPMENT OF MYELOPEROXIDASE INHIBITORS TO TREAT ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) g. Oxidative Stress Researcher and Organization Principal Investigator MAKI, RICHARD Principal Investigator First Name RICHARD Principal Investigator Last Name MAKI Awardee Organization TORREY PINES PHARMACEUTICALS, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-11-096: PHS 2011-02 OMNIBUS SOLICITATION OF THE NIH, CDC, FDA AND ACF FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PARENT SBIR [R43/R44]) FY Overall Cost $255,109 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official BUCKHOLTZ, NEIL
